发明名称 Delavirdine high strength tablet formulation
摘要 Disclosed is a non-sustained release pharmaceutical tablet composition which comprises a rapidly precipitating drug in an amount from about 5 to about 60% and at least one member selected from the group consisting of a binder in an amount of from about 2 to about 25% and a superdisintegrant in an amount from about 6 to about 40% where the rapidly precipitating drug, "binder" and superdisintegrant are mixed and compressed into a tablet without heating, solvent or grinding.
申请公布号 US6177101(B1) 申请公布日期 2001.01.23
申请号 US19990327135 申请日期 1999.06.07
申请人 发明人
分类号 A61K9/20;A61K31/496;A61K47/02;A61K47/26;A61K47/32;A61K47/36;A61K47/38;(IPC1-7):A61K9/20;A01N43/58;A01N43/60 主分类号 A61K9/20
代理机构 代理人
主权项
地址